248 filings
DEFA14A
CARA
Cara Therapeutics Inc
22 Apr 24
Additional proxy soliciting materials
4:08pm
ARS
2023 FY
CARA
Cara Therapeutics Inc
22 Apr 24
Annual report to shareholders
4:07pm
DEF 14A
CARA
Cara Therapeutics Inc
Definitive proxy
22 Apr 24
4:05pm
PRE 14A
CARA
Cara Therapeutics Inc
12 Apr 24
Preliminary proxy
4:15pm
8-K
CARA
Cara Therapeutics Inc
22 Mar 24
Departure of Directors or Certain Officers
4:05pm
S-8
w3s94c
6 Mar 24
Registration of securities for employees
4:45pm
8-K
j8xiw
4 Mar 24
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
4:10pm
8-K
q9h e8upq1
2 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:59pm
8-K
ldon pb25f
22 Jan 24
Cost Associated with Exit or Disposal Activities
4:19pm
8-K
03zqhim2vhf25wbcb
18 Dec 23
Regulation FD Disclosure
7:10am
8-K
ma5 w75amjnt
13 Nov 23
Corporate Presentation November 2023
4:28pm
8-K
ln9cafvw1dd q8oj
13 Nov 23
Cara Therapeutics Reports Third Quarter 2023 Financial Results
4:11pm
8-K
x8e r093939zq
2 Nov 23
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
7:10am
8-K
zu1s49z
7 Aug 23
Corporate Presentation August 2023
4:24pm
8-K
riz6jm dz
7 Aug 23
Cara Therapeutics Reports Second Quarter 2023 Financial Results
4:10pm
8-K
zs3ryu psr5u5
3 Aug 23
Cara Therapeutics Appoints Helen M. Boudreau to
7:06am
8-K
k2tnupr1ugi
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm